About KDRA
Overview of KDRA
In 1986 Korea Drug Research Association(KDRA), Korean Pharmaceutical Innovators’ Group was established as non-profit organization to cope with the introduction of a new product patent system based on the law for fostering industrial technology association and represents R&D based pharmaceutical & biotech industry in Korea.
From its establishment KDRA has been working for the development of Korean Pharmaceutical & Biotech industries promoting the industrial technologies in pharmaceutical & biotech fields. For this KDRA has been participating in and leading biotech R&D policy-making, strategy formulating and improvement of advanced R&D systems. KDRA has since 1986 engaged in mid-and long-term nat'l R&D programs, drived and managed various kinds of R&D programs including those sponcered by the government in several innovation areas; NCE, NME, API, herbal medicine, New Indication, New Route of Administration, New Formulation, New Ester, Salt or Other Non-covalent Derivative, New Dosage Form or Strength, Combination Product etc.
KDRA has also been working in business partnering and technology transfer & licensing between the pharmaceutical & biotech industries, academic and public research organizations domestically and internationally. For these activities, KDRA has since 2002 been organizing annual business partnering event, InterBiz Bio-Partnering & Investment Forum, a key conference for technology transfer & collaboration with average 700 domestic & international companies & orgs.
To provide the industry with additional opportunities for domestic & global business development, KDRA has established and is managing a distinctive subsidiary organization, PTBC(PharmaTech Business Center) for providing services in technology transfer, licensing and R&D collaboration activities between KDRA members and domestic & international partners.
To cope with the global mega trends and environmental changes surrounding the pharmaceutical industry in several areas; market, technology, regulation and business, KDRA has since 1994 established several subsidiary associations; Korea Association of Research for API(1994), Korean Association of Research for Pharmaceutical Analysis(2007), Korean Association of Natural Products Development(2011), Korea Business Development Professional’s Group(2017) and Korean Society of Convergent Research on Microneedle Systems (2023). Additionally to provide theoretical & statistical approaches to the industry of its importance and contribution to the promotion of national healthcare, reduction of healthcare budget and control & management of life threatening, chronic and intractable diseases of the population, KDRA has in 2010 established Innovation Policy Research Center(InnoPol)